Form D · Pharmaceuticals
Vigil Neuroscience, Inc.
Cambridge, MA · CIK 0001827087
Offering snapshot reported Aug 29, 2022 · SEC filing
- Reported sold
- $75M Offering amount: $75M
- Investors reported
- 9 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 16, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 29, 2022 | Initial | $74,999,705 | No comparison | 9 | SEC filing |
| Aug 25, 2021 | Initial | $89,999,961 | No comparison | Not reported | SEC filing |
| Jun 15, 2021 | Amendment | $49,999,989 | $19,999,994vs Oct 5, 2020 | 6 | SEC filing |
| Oct 5, 2020 | Initial | $29,999,995 | No comparison | 6 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $3.38M
- Finders' fees
- $0
- Form D file number
- 021-457309
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Jefferies LLC | 2347 |
Source: Form D, filed Aug 29, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Cheryl Blanchard | Director |
| Cheryl Blanchard, Ph. D. | Director |
| Bruce Booth | Director |
| Suzanne Bruhn | Director |
| Shaan Gandhi | Director |
| Gerhard Koenig | Director |
| Ivana Magovcevic Liebisch | Director, Executive |
| Spyros Papapetropoulos | Executive |
| Evan Thackaberry | Executive |
| Mary Thistle | Director |
| Clay Thorp | Director |
| Christopher Verni | Executive |
| Stefan Vitorovic | Director |
| Jennifer Ziolkowski | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
1 Broadway, 7 Th Floor, Suite 07 300
Cambridge, MA, 02142
Cambridge, MA, 02142